Skip to main content
. Author manuscript; available in PMC: 2017 Feb 28.
Published in final edited form as: Neuroscience. 2015 Jul 9;303:378–388. doi: 10.1016/j.neuroscience.2015.07.013

Fig. 10.

Fig. 10

Protein levels of TRPM8GFP, VGLUT1 and VGLUT2 in the TG in the control group and CFA-treated group. (A) Western blot assay. (B) Protein levels (Mean ± SE) of TRPM8GFP and VGLUT1 are not significantly different between the control group and the CFA-treated group. However, the protein level of VGLUT2 is significantly higher in the CFA-treated group than in the control group. N = 5 animals per group. *p < 0.05.